ID
33946
Description
A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis; ODM derived from: https://clinicaltrials.gov/show/NCT00800202
Link
https://clinicaltrials.gov/show/NCT00800202
Keywords
Versions (1)
- 1/9/19 1/9/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 9, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Small Cell Lung Cancer NCT00800202
Eligibility Non-Small Cell Lung Cancer NCT00800202
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Prior Therapy Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0220650
Description
Migraine Disorders | Epilepsy
Data type
boolean
Alias
- UMLS CUI [1]
- C0149931
- UMLS CUI [2]
- C0014544
Description
Angiogenesis Inhibitors
Data type
boolean
Alias
- UMLS CUI [1]
- C0596087
Description
Avastin | Tarceva
Data type
boolean
Alias
- UMLS CUI [1]
- C1135130
- UMLS CUI [2]
- C1135136
Description
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004057
- UMLS CUI [1,2]
- C0456683
- UMLS CUI [2,1]
- C0003280
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0443225
- UMLS CUI [3]
- C0016018
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00800202
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C3258246 (UMLS CUI [1,2])
C0231221 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
C0220650 (UMLS CUI [1,2])
C0014544 (UMLS CUI [2])
C1135136 (UMLS CUI [2])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
No comments